INFI - Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q3 2018 Results - Earnings Call Transcript
Infinity Pharmaceuticals, Inc. (INFI)
Q3 2018 Earnings Conference Call
November 5, 2018 4:30 PM ET
Executives
Jayne Kauffman — Senior Executive Coordinator
Adelene Perkins — Chief Executive Officer
Larry Bloch — President
Sam Agresta — Chief Medical Officer
Jeff Kutok — Chief Scientific Officer
Analysts
Joseph Civello — Wells Fargo Securities
Tessa Romero — J.P. Morgan
Presentation
Operator
Operator Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals conference call to discuss the Company's financial results for the third quarter 2018. My name is Crystal, and I'll be your operator for